Monopar Therapeutics (MNPR) Institutional Ownership $43.15 +1.33 (+3.18%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$41.44 -1.71 (-3.96%) As of 08:27 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Monopar Therapeutics (NASDAQ:MNPR)CurrentInstitutional OwnershipPercentage1.83%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$54.80MNumber ofInstitutional Sellers(last 12 months)0 Get MNPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Monopar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MNPR Institutional Buying and Selling by Quarter Monopar Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/23/2025 Gerber LLC5,601$204K0.2%N/A0.092% 2/17/2025Point72 Asset Management L.P.167,892$3.69M0.0%N/A2.752% 2/17/2025Janus Henderson Group PLC1,046,899$23.44M0.0%N/A17.162% 2/14/2025RA Capital Management L.P.511,207$11.25M0.1%N/A8.380% 2/14/2025Adage Capital Partners GP L.L.C.599,195$13.18M0.0%N/A9.823% 2/13/2025ADAR1 Capital Management LLC130,037$2.86M0.6%N/A2.132% 2/12/2025Geode Capital Management LLC38,596$849K0.0%+174.4%0.633% 2/12/2025JPMorgan Chase & Co.2,037$45K0.0%N/A0.033% 10/31/2023Windsor Advisory Group LLC89,974$56K0.1%N/A0.635% 8/13/2021Geode Capital Management LLC28,761$169K0.0%+9.0%0.229% 8/13/2021Vanguard Group Inc.97,462$574K0.0%+116.2%0.775% 5/21/2021Citadel Advisors LLC12,479$77K0.0%N/A0.099% 5/18/2021Citadel Advisors LLC12,479$77K0.0%N/A0.099% 5/17/2021Royal Bank of Canada9,130$57K0.0%N/A0.073% 5/12/2021Northern Trust Corp36,001$223K0.0%-38.8%0.286% 5/12/2021Geode Capital Management LLC26,394$163K0.0%N/A0.210% 5/7/2021BlackRock Inc.11,229$70K0.0%+108.3%0.089% (Data available from 1/1/2016 forward) MNPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MNPR shares? During the previous two years, 9 institutional investors and hedge funds held shares of Monopar Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($23.44M), Adage Capital Partners GP L.L.C. ($13.18M), RA Capital Management L.P. ($11.25M), Point72 Asset Management L.P. ($3.69M), ADAR1 Capital Management LLC ($2.86M), Geode Capital Management LLC ($849K), and Gerber LLC ($204K).Learn more on MNPR's institutional investors. What percentage of Monopar Therapeutics stock is owned by institutional investors? 1.83% of Monopar Therapeutics stock is owned by institutional investors. Learn more on MNPR's institutional investor holdings. Which institutional investors have been buying Monopar Therapeutics stock? Of the 9 institutional investors that purchased Monopar Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($1.05M), Adage Capital Partners GP L.L.C. ($599.20K), RA Capital Management L.P. ($511.21K), Point72 Asset Management L.P. ($167.89K), ADAR1 Capital Management LLC ($130.04K), Windsor Advisory Group LLC ($89.97K), and Geode Capital Management LLC ($24.53K). How much institutional buying is happening at Monopar Therapeutics? Institutional investors have bought a total of 2,577,372 shares in the last 24 months. This purchase volume represents approximately $55.08M in transactions. Related Companies Syndax Pharmaceuticals Major Shareholders Adaptive Biotechnologies Major Shareholders Iovance Biotherapeutics Major Shareholders Wave Life Sciences Major Shareholders 89bio Major Shareholders Collegium Pharmaceutical Major Shareholders Mineralys Therapeutics Major Shareholders Intellia Therapeutics Major Shareholders Spyre Therapeutics Major Shareholders Zymeworks Major Shareholders This page (NASDAQ:MNPR) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MNPR Stock Free MNPR Stock Alerts